Two Sigma Advisers
SCMP

Two Sigma Advisers’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Two Sigma Advisers’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-231,945
Closed -$4.16M – 2503
2017
Q4 		$4.16M Buy
231,945
+202,000
+675% +$2.49M 0.01% 918
2017
Q3 		$353K Sell
29,945
-7,400
-20% -$83K ﹤0.01% 1866
2017
Q2 		$392K Sell
37,345
-8,600
-19% -$87.7K ﹤0.01% 1877
2017
Q1 		$505K Sell
45,945
-22,000
-32% -$255K ﹤0.01% 1896
2016
Q4 		$921K Buy
67,945
+12,600
+23% +$176K ﹤0.01% 1600
2016
Q3 		$681K Sell
55,345
-85,500
-61% -$1.01M ﹤0.01% 1530
2016
Q2 		$1.54M Sell
140,845
-49,600
-26% -$555K 0.01% 969
2016
Q1 		$2.08M Buy
190,445
+10,566
+6% +$134K 0.01% 792
2015
Q4 		$3.11M Sell
179,879
-37,786
-17% -$677K 0.02% 607
2015
Q3 		$4.42M Buy
217,665
+155,720
+251% +$3.57M 0.03% 503
2015
Q2 		$1.02M Sell
61,945
-6,100
-9% -$106K 0.01% 1121
2015
Q1 		$1.06M Buy
68,045
+4,400
+7% +$68.2K 0.01% 1044
2014
Q4 		$909K Buy
63,645
+43,500
+216% +$459K 0.01% 1219
2014
Q3 		$131K Buy
20,145
+4,000
+25% +$26.6K ﹤0.01% 2194
2014
Q2 		$111K Buy
+16,145
New +$114K ﹤0.01% 2353

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Two Sigma Advisers's SCMP Position: Q1 2018 in Review

Two Sigma Advisers sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 231,945 shares — an estimated $4.16M sold.

Two Sigma Advisers first reported a position in SCMP in Q2 2014 and held it in 15 quarters. The position peaked at $4.42M in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Two Sigma Advisers reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Two Sigma Advisers sold 231,945 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $4.16M.
  • Two Sigma Advisers first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2014 and held it in 15 quarters.
  • Two Sigma Advisers's Sucampo Pharmaceuticals, Inc. position peaked at $4.42M in Q3 2015.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Two Sigma Advisers's 13F filing for Q1 2018, filed 15 May 2018.